Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

108094 Press Releases
DateTitleCompany
08 Feb 16 BD Launches BD FACSymphony™ High-Speed Cell Analyzer to Enable Identification and Analysis of Rare Cell Types BD (Becton, Dickinson and Company),
Published by
PR Newswire
08 Feb 16 Astellas Names James Robinson President, Americas Operations Astellas Pharma Inc.,
Published by
PR Newswire
08 Feb 16 NanoViricides CEO to Present at the 18th Annual BIOCEO & Investor Conference on February 8, 2016 and at the Disruptive Growth and Healthcare Conference on February 11, 2016, both in New York City NanoViricides, Inc.,
Published by
PR Newswire
08 Feb 16 Sangamo BioSciences Announces FDA Clearance Of Investigational New Drug Application For ZFN-Mediated Genome Editing Treatment Of MPS I Sangamo BioSciences, Inc.,
Published by
PR Newswire
08 Feb 16 The Economist Events' Value-based Healthcare in Europe 2016 The Economist Events,
Published by
PR Newswire
08 Feb 16 Healthcare Cognitive Computing Market Worth $5.0Bn By 2022: Grand View Research, Inc. Grand View Research, Inc,
Published by
PR Newswire
08 Feb 16 Ferring announces the start of the PRONOUNCE Trial for patients with advanced prostate cancer and cardiovascular disease receiving degarelix or leuprolide Ferring Pharmaceuticals,
Published by
Business Wire
08 Feb 16 Global Gastrointestinal Partnering Deal Trends, Players and Financials 2010-2016 - Research and Markets Research and Markets,
Published by
Business Wire
08 Feb 16 Global Drug Hypersensitivity Reactions Clinical Trials Review, H2, 2015 - Analysis, Technologies & Forecast Report - Key Vendors: Valeant Pharmaceuticals, Ligand Pharmaceuticals & Amgen - Research and Markets Research and Markets,
Published by
Business Wire
08 Feb 16 Global Genitourinary Partnering 2010-2016: Deal Trends, Players and Financials Analysis - Research and Markets Research and Markets,
Published by
Business Wire
08 Feb 16 Atherosclerosis Therapeutics Development Pipeline Review, H2 2015 - Research and Markets Research and Markets,
Published by
Business Wire
08 Feb 16 B-Cell Non-Hodgkin Lymphoma Pipeline Review, H2 2015 Featuring 100+ Companies & their Drug Profiles - Research and Markets Research and Markets,
Published by
Business Wire
08 Feb 16 Pihlajalinna Plc:Pihlajalinna's Itä-Suomen Lääkärikeskus acquisition finalized Pihlajalinna Oyj,
Published by
GlobeNewswire
08 Feb 16 RCare Unveils New Website and Product Catalog RCare,
Published by
PR Newswire
08 Feb 16 RCare Unveils New Look for Website and Catalog RCare,
Published by
PR Newswire
08 Feb 16 COPD Market Epidemiology 2023 Forecasts for 8 Major Markets RnR Market Research,
Published by
PR Newswire
08 Feb 16 KPI Therapeutics Announces Expanded Drug Programs in Eye and Skin Diseases KPI Therapeutics, Inc.,
Published by
Business Wire
08 Feb 16 DBV Technologies to Present at the LEERINK Partners 5th Annual Global Healthcare Conference DBV Technologies,
Published by
GlobeNewswire
08 Feb 16 ASTRAZENECA’S COMBINATION OF DURVALUMAB WITH TREMELIMUMAB SHOWS CLINICAL ACTIVITY IN NON-SMALL CELL LUNG CANCER IRRESPECTIVE OF PD-L1 STATUS AstraZeneca,
Published by
Business Wire
08 Feb 16 STENTYS initiates the Commercialization of the first Self-Expanding Drug-Eluting stent for the Below-The-Knee Indication STENTYS,
Published by
Business Wire
08 Feb 16 Implanet Announces the Appointment of Brian T. Ennis to Head Its US Subsidiary IMPLANET,
Published by
Business Wire
08 Feb 16 Ideal Cures Pvt. Ltd.: Ideal Cures Expands its Global Reach with a Presence in America Ideal Cures Pvt. Ltd.,
Published by
Business Wire
08 Feb 16 Oasmia Has Submitted a Marketing Authorization Application to the European Medicines Agency for Its Lead Cancer Product Apealea® (Paclical®) Oasmia Pharmaceutical AB,
Published by
PR Newswire
08 Feb 16 RowdMap, Inc. Speaks at HIMSS on Using New Data on Populations and Providers to Succeed in New Value Based Payment Models, without IT Published by
GlobeNewswire
08 Feb 16 DBV Technologies to Present at the LEERINK Partners 5th Annual Global Healthcare Conference Published by
GlobeNewswire
08 Feb 16 VALNEVA Signs New R&D Collaboration with GlaxoSmithKline for the EB66(r) Cell Line Published by
GlobeNewswire
08 Feb 16 INNATE PHARMA : Start of Phase I clinical trial of monalizumab in combination with durvalumab Published by
GlobeNewswire
08 Feb 16 AXINESIS Obtains CE Mark for REAplan, its Medical Interactive Rehabilitation Device Axinesis,
Published by
PR Newswire
08 Feb 16 Could Exercise Improve Prostate Cancer Survival? Dr. David Samadi,
Published by
PR Newswire
08 Feb 16 INNATE PHARMA : Start of Phase I clinical trial of monalizumab in combination with durvalumab INNATE PHARMA,
Published by
GlobeNewswire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.